Menu Back to Patient-Engagement-throughout-the-Full-Spectrum-of-Drug-Development-An-Interactive-Workshop-for-Life-Science-Companies-and-Patient-Groups

Program Committee

  • Carl  Chiang
    Carl Chiang Director, Clinical Development
    Zinfandel Pharmaceuticals, United States
  • Marcia K. Horn, JD
    Marcia K. Horn, JD President and CEO
    ICAN, International Cancer Advocacy Network, United States
  • Lawrence Eugene Liberti, MS, RPh, RAC
    Lawrence Eugene Liberti, MS, RPh, RAC Executive Director
    Centre for Innovation in Regulatory Science (CIRS), United States
  • Elizabeth  Lincoln, MA
    Elizabeth Lincoln, MA Global Director of Engagement
    DIA, United States
  • Peter  Loupos, MS
    Peter Loupos, MS Partners in Patient Health, US Corporate Affairs
    Sanofi, United States
  • Prasun  Subedi, PhD, MS
    Prasun Subedi, PhD, MS Associate Director
    Pfizer Inc, United States
  • FDA Speaker  Invited
    FDA Speaker Invited
    FDA, United States
  • Suzanne  Schrandt, JD
    Suzanne Schrandt, JD Director, Patient Engagement
    Arthritis Foundation, United States
  • Lona  Vincent, MPH
    Lona Vincent, MPH Senior Associate Director
    Michael J. Fox Foundation For Parkinson's Research, United States
Load More

Digital Learning Catalog

eLearning Catalog Cover